InvestorsHub Logo
Followers 79
Posts 24490
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Friday, 10/13/2017 8:34:48 AM

Friday, October 13, 2017 8:34:48 AM

Post# of 27395
ONCS - 1.20

OncoSec Medical Says ImmunoPulse IL-12 Demonstrated 33.5% Best Overall Response Rate in Melanoma Patients



Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.